Pancreatic neuroendocrine neoplasms (PNENs) represent the second most common type of pancreatic tumors, with an incidence rate of approximately 0.32–0.48 per 100,000 individuals [1,2]. In recent years, advancements in imaging techniques and heightened health awareness have significantly increased the detection rates of PNENs. On contrast-enhanced computed tomography (CT), PNENs typically appear as isolated homogenously hyperdense mass, indicative of their hypervascular nature [3]. However, up to…